| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.048 | 0.4 |